Trial intelligence / Profile preview

Perioperative enrikefon-based multimodal analgesia in thoracoscopic lung resection

ChiCTR2500109513Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Anhui Medical University
Start
Sep 2025
Modality
Peptides, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of LAUR-004 in postoperative fatigue and postoperative pain (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Postoperative fatigue syndrome. Planned start Sep 2025; status: not yet recruiting.

02

Drugs

LAUR-004
03

Conditions

postoperative fatiguepostoperative pain

Beyond the preview

Go deeper on ChiCTR2500109513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500109513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call